14-221 - Specimen Collection From Pregnant Women Who are at Increased Risk for Fetal Chromosome Disorder
Status: openCollection of Whole Blood Specimens from Pregnant Women at Increased Risk for Fetal Chromosomal Abnormality for use in Development of a Noninvasive Prenatal Test in Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma
Treatment for Fetal Aneuploidy / Down Syndrome
Contact Us
If you have questions about this trial or are interested in participating, please contact this Clinical Trial’s Coordinator by email at clinical.trials@health.southalabama.edu.
Description
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21. IRB Number 14-221
Sponsors
This trial is sponsored by Sequenom, Inc..Providers Associated With This Trial
Principle Investigator
This link will open in a new tab or window.